首页> 外文OA文献 >Hollow Mesoporous Silica/Poly(l-lysine) Particles for Codelivery of Drug and Gene with Enzyme-Triggered Release Property
【2h】

Hollow Mesoporous Silica/Poly(l-lysine) Particles for Codelivery of Drug and Gene with Enzyme-Triggered Release Property

机译:空心中孔二氧化硅/聚(l-赖氨酸)颗粒用于药物和基因的酶促释放释放

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We designed, for the first time, an enzyme-triggered drug and gene codelivery system combining hollow mesoporous silica (HMS) with enzyme degradable poly(l-lysine) (PLL) polymer to form HMS/PLL particles driven by electrostatic interaction between negatively charged gene and positively charged PLL polymer on the drug-loaded HMS particles. Fluorescein and cytosine–phosphodiester–guanine oligodeoxynucleotide (CpG ODN) were used as the model drug and gene, and the loading and the layer-by-layer assembly were evaluated by UV/vis analysis, zeta potential measurement, and gel electrophoresis. The fluorescein and CpG ODN loading capacities of the MFHMS/(CpG/PLL)3 particles were 28.8 and 97.1 μg/mg, respectively. Importantly, in vitro release results showed that the MFHMS/(CpG/PLL)3 particles exhibited an enzyme-triggered controlled release of fluorescein and CpG ODN simultaneously in the α-chymotrypsin solution, and the release rates of fluorescein and CpG ODN could also be controlled by changing the enzyme concentration. Therefore, this system has the advantages of both enzyme-triggered controlled release and codelivery of drug and gene and would have potential and promising applications in the field of biomedicine and cancer therapy.
机译:我们首次设计了一种酶触发的药物和基因密码传递系统,该系统将中空介孔二氧化硅(HMS)与可酶降解的聚(l-赖氨酸)(PLL)聚合物相结合,形成由负电荷之间的静电相互作用驱动的HMS / PLL颗粒载药的HMS颗粒上带有一个基因和带正电的PLL聚合物。荧光素和胞嘧啶-磷酸二酯-鸟嘌呤寡聚脱氧核苷酸(CpG ODN)被用作模型药物和基因,并通过紫外/可见分析,ζ电势测量和凝胶电泳评估了载量和逐层组装。 MFHMS /(CpG / PLL)3颗粒的荧光素和CpG ODN负载量分别为28.8和97.1μg/ mg。重要的是,体外释放结果表明MFHMS /(CpG / PLL)3颗粒在α-胰凝乳蛋白酶溶液中同时显示了荧光素和CpG ODN的酶触发控制释放,并且荧光素和CpG ODN的释放速率也可以是通过改变酶浓度来控制。因此,该系统既具有酶触发的控释作用,又具有药物和基因的代码传递的优点,在生物医学和癌症治疗领域具有潜在的应用前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号